Cardiol Therapeutics (CRDL) Exchange Rate Effect (2022 - 2026)
Cardiol Therapeutics (CRDL) posted Exchange Rate Effect of $161840.6 for Q1 2026, down 39.68% on a QoQ basis from $268294.7 in Q3 2025, and up 315.47% year-over-year from $38954.1 in Q1 2025.
Cardiol Therapeutics (CRDL) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Cardiol Therapeutics' Exchange Rate Effect history runs 5 years deep, the most recent figure standing at $161840.6 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | 161,840.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161,840.64 |
| Mar 31, 2026 | 161,840.64 |
| Sep 30, 2025 | 268,294.72 |
| Sep 30, 2025 | 268,294.72 |
| Jun 30, 2025 | -404,918.24 |
| Jun 30, 2025 | -404,918.24 |
| Mar 31, 2025 | -75,112.26 |
| Mar 31, 2025 | -75,112.26 |
| Sep 30, 2024 | -259,981.06 |
| Sep 30, 2024 | -259,981.06 |
| Jun 30, 2024 | 109,437.85 |
| Jun 30, 2024 | 109,437.85 |
| Mar 31, 2024 | 364,449.57 |
| Mar 31, 2024 | 364,449.57 |
| Sep 30, 2023 | -722,212.12 |
| Sep 30, 2023 | -722,212.12 |
| Jun 30, 2023 | 630,201.35 |
| Jun 30, 2023 | 630,201.35 |
| Mar 31, 2023 | 2,041.56 |
| Mar 31, 2023 | 2,041.56 |